RSS

Amyotrophic Lateral Sclerosis (ALS)

Oxford BioDynamics is expanding its biomarker discovery programme for the development of companion diagnostic tests for Amyotrophic Lateral Sclerosis (ALS), using its EpiSwitch technology more

News